CAS number：1338320-94-7 molecular formula：C17H16N2O4S
MPT0E028 is an orally active and selective HDAC inhibitor with IC 50 s of 53.0 nM, 106.2 nM, 29.5 nM for HDAC1 , HDAC2 and HDAC6 , respectively. MPT0E028 reduces the viability of B-cell lymphomas by inducing apoptosis and possesses potent direct Akt targeting ability and reduces Akt phosphorylation in B-cell lymphoma. MPT0E028 has good anticancer activity . Form:Solid
| Chinese alias | - | ||
| English alias | MPT0E028 | HY-124295 | Q27289720 | 1338320-94-7 | (E)-3-[1-(benzenesulfonyl)-2,3-dihydroindol-5-yl]-N-hydroxyprop-2-enamide | T65L58FI65 | 2-Propenamide, 3-(2,3-dihydro-1-(phenylsulfonyl)-1H-indol-5-yl)-N-hydroxy- | MS-25283 | SCHEMBL2511433 | UNII-T65L58 | ||
| CAS number | 1338320-94-7 | molecular formula | C17H16N2O4S |
| molecular weight | 344.38 g/mol | Exact mass | ≥99% |
| PSA | 95.100 Ų | logp | 1.900 |
No numbering system information yet
No physical and chemical property information yet
No safety information yet
No production method and use information yet
No upstream information yet
No downstream information yet
